Selecting use of proteasome inhibitors based on NF-κB2 sequence

Invention Grant

US09856534B2 Selecting use of proteasome inhibitors based on NF-κB2 sequence 有权

Patent Title: Selecting use of proteasome inhibitors based on NF-κB2 sequence
Application No.: US14114605

Application Date: 2012-04-27
Publication No.: US09856534B2

Publication Date: 2018-01-02
Inventor: Leon Bernal-Mizrachi
Applicant: Leon Bernal-Mizrachi
Applicant Address: US GA Atlanta
Assignee: Emory University
Current Assignee: Emory University
Current Assignee Address: US GA Atlanta
Agency: Kilpatrick Townsend & Stockton, LLP
International Application: PCT/US2012/035590 WO 20120427
International Announcement: WO2012/149419 WO 20121101
Main IPC: C12Q1/68
IPC: C12Q1/68 ; A61K31/145 ; A61K31/336 ; A61K31/351 ; A61K31/4015 ; A61K31/4965 ; A61K31/69

Abstract:

Provided herein are methods for selecting use of proteasome inhibitors.

Public/Granted literature

Information query

Espacenet

IPC分类:

C	化学；冶金
C12	生物化学；啤酒；烈性酒；果汁酒；醋；微生物学；酶学；突变或遗传工程
C12Q	包含酶、核酸或微生物的测定或检验方法（免疫检测入G01N33/53）；其所用的组合物或试纸；这种组合物的制备方法；在微生物学方法或酶学方法中的条件反应控制
C12Q1/00	包含酶、核酸或微生物的测定或检验方法（带有条件测量或传感器的测定或试验装置，如菌落计数器入C12M1/34）；其组合物；这种组合物的制备方法
C12Q1/68	.包括核酸